Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino(Shimane University), Takeshi Isobe(Shimane University)OncotargetMarch 30, 201810.18632/oncotarget.24704Cited by 32SaveCiteExport RISWatch citationsRelated PapersProtein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer|Respiratory Research|2019|50